ADMA Biologics
ADMA
$9.55
Share price
0.74%
Change (1 day)
138.15%
Change (1 year)
Categories
Market capitalization of ADMA Biologics (ADMA)
Market cap: $2.21 Billion
As of June 2024 ADMA Biologics has a market cap of $2.21 Billion. This makes ADMA Biologics the world's 3957th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ADMA Biologics from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.21 B | 116.74% |
| 2023 | $1.02 B | 19.17% |
| 2022 | $0.85 B | 210.44% |
| 2021 | $0.27 B | 49.75% |
| 2020 | $0.18 B | -22.3% |
| 2019 | $0.23 B | 114.19% |
| 2018 | $0.11 B | -23.85% |
| 2017 | $0.14 B | 120.47% |
| 2016 | $65.98 M | -23.68% |
| 2015 | $86.45 M | -16.7% |
| 2014 | $0.10 B | 43.21% |
| 2013 | $72.47 M |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of ADMA Biologics was reported to be:
$2.21 Billion
$2.21 Billion
$2.21 Billion
$2.21 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $8.33 B | 276.30% | 🇺🇸 USA |
 Novavax NVAX | $2.21 B | 0.01% | 🇺🇸 USA |
 Cel-Sci
CVM | $65.53 M | -97.04% | 🇺🇸 USA |